NRC Financials Nrc Health

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated 41 d ago Overview →

Growth & profitability

Revenue has grown 0.6% per year over the past 5 years.
Net income has grown slower than revenue (-25.4% vs 0.6% per year).
Operating margin has contracted, at 16.4% in the latest year.
Free cash flow has declined 15.5% per year over the past 5 years.

Financial health

Total debt ($79M) exceeds cash ($4M); net debt is $75M.
Total debt has grown faster than revenue (20.8% vs 0.6% per year).
Operating income covered interest expense 4.7× in the latest year.
Total debt is 2.6× EBITDA.

Shareholder returns

Dividends have been paid for 11 consecutive years, consuming 94.6% of earnings and 69.7% of free cash flow.
The dividend has grown 0.9% per year over the past 5 years.

Revenue & net income

RevenueNet income

Margins (gross / operating / net)

GrossOperatingNet

Return on equity & assets (ROE / ROA)

ROEROA

Free cash flow (CFO − capex)

Free cash flow

Cash vs total debt

CashTotal debt

Cash flow: operating / investing / financing

OperatingInvestingFinancing

Key annual figures

FY	Revenue	Net income	Gross M	Op M	ROE	ROA	FCF	Total debt	Cash
2025	$137M	$12M	0.0%	16.4%	82.9%	8.6%	$16M	$79M	$4M
2024	$143M	$25M	0.0%	24.6%	79.2%	18.7%	$19M	$58M	$4M
2023	$149M	$31M	0.0%	27.0%	63.3%	25.3%	$22M	$37M	$7M
2022	$152M	$32M	0.0%	30.7%	44.1%	24.4%	$26M	$22M	$25M
2021	$148M	$37M	0.0%	34.0%	43.9%	23.8%	$41M	$27M	$54M
2020	$133M	—	0.0%	32.0%	0.0%	0.0%	$37M	$31M	$35M
2019	$128M	—	0.0%	33.6%	0.0%	0.0%	$36M	$34M	$14M
2018	$120M	$30M	0.0%	29.5%	157.5%	27.8%	$34M	$38M	$13M
2017	$118M	$23M	0.0%	29.1%	25.5%	18.0%	$24M	$1M	$35M
2016	—	$21M	—	—	24.8%	17.0%	$23M	$4M	$33M
2015	—	$18M	—	—	23.7%	13.8%	$19M	$6M	$42M
2014	—	$18M	—	—	20.7%	14.0%	$24M	$8M	$40M
2013	—	$15M	—	—	21.6%	13.9%	$17M	$10M	$22M
2012	—	$15M	—	—	26.6%	15.1%	$17M	$12M	$8M
2011	—	$12M	—	—	20.8%	11.5%	$16M	$14M	$8M

Revenue & net income

RevenueNet income

Margins (gross / operating / net)

GrossOperatingNet

Return on equity & assets (ROE / ROA)

ROEROA

Free cash flow (CFO − capex, quarterly)

Free cash flow

Cash vs total debt

CashTotal debt

Cash flow: operating / investing / financing

OperatingInvestingFinancing

Key quarterly figures

Quarter	Revenue	Net income	Gross M	Op M	ROE	ROA	FCF	Total debt	Cash
Jun '26	$35M	-$3M	0.0%	-9.1%	-50.1%	-2.4%	$62000	$90M	$3M
Mar '26	$35M	$3M	0.0%	16.0%	23.9%	2.4%	$5M	$74M	$3M
Dec '25	$35M	—	0.0%	13.3%	0.0%	0.0%	$6M	$79M	$4M
Sep '25	$35M	—	0.0%	22.4%	0.0%	0.0%	$10M	$76M	$2M
Jun '25	$34M	-$106000	0.0%	4.7%	-0.5%	-0.1%	-$4M	$77M	$5M
Mar '25	$34M	$6M	0.0%	25.6%	19.5%	4.3%	$4M	$59M	$3M
Dec '24	$37M	—	0.0%	26.0%	0.0%	0.0%	$2M	$58M	$4M
Sep '24	$36M	—	0.0%	22.3%	0.0%	0.0%	$8M	$49M	$3M
Jun '24	$35M	—	0.0%	25.3%	0.0%	0.0%	$2M	$33M	$485000
Mar '24	$35M	—	0.0%	24.8%	0.0%	0.0%	$8M	$35M	$2M
Dec '23	$38M	—	0.0%	30.8%	0.0%	0.0%	$8M	$37M	$7M
Sep '23	$38M	—	0.0%	26.2%	0.0%	0.0%	$5M	$19M	$4M
Jun '23	$36M	—	0.0%	25.9%	0.0%	0.0%	$4M	$20M	$22M
Mar '23	$36M	—	0.0%	24.7%	0.0%	0.0%	$5M	$21M	$24M
Dec '22	$38M	—	0.0%	32.1%	0.0%	0.0%	$6M	$22M	$25M
Sep '22	$38M	—	0.0%	29.5%	0.0%	0.0%	$6M	$23M	$28M
Jun '22	$37M	—	0.0%	30.8%	0.0%	0.0%	$8M	$24M	$33M
Mar '22	$38M	—	0.0%	30.4%	0.0%	0.0%	$6M	$26M	$47M
Dec '21	$38M	—	0.0%	33.6%	0.0%	0.0%	$10M	$27M	$54M
Sep '21	$38M	—	0.0%	34.8%	0.0%	0.0%	$8M	$28M	$52M

Valuation over time

How the market has priced NRC against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

The price-to-earnings ratio has risen from 30.3× (Mar '23) to 40.5× (Sep '26).
The price-to-sales ratio has fallen from 6.3× (Mar '23) to 3.4× (Sep '26).
The dividend yield has risen from 2.2% (Mar '23) to 2.3% (Sep '26).

Price / earnings (P/E)

P/E

Price / sales (P/S)

P/S

Dividend yield (%)

Dividend yield %

Frequently asked questions

Is NRC growing its revenue and profit?

Over the past 5 years, Nrc Health's revenue has grown 0.6% per year, and net income declined 25.4% per year. These are computed facts, not advice.

How much debt does NRC have?

As of FY2025, Nrc Health reported $79M of total debt against $4M of cash; operating income covered interest expense 4.7×.

What is NRC's profit margin?

In FY2025, gross margin was —, operating margin 16.4%, and net margin 8.4%.

What is NRC's P/E ratio?

As of Sep '26, Nrc Health traded at a price-to-earnings ratio of about 40.5× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.